Abstract
Background
Anti-pituitary antibodies (APA) were described in patients with Type 1 Diabetes (T1D) but their prevalence and relevance remain controversial.
Materials and methods
We evaluated the APA prevalence in Sardinian sera from 100 T1D patients, 70 Type 2 Diabetes (T2D) patients and 62 healthy controls, using indirect immunofluorescence on bovine pituitary sections. To compare two different substrates, we tested using bovine sections, further T1D patient sera (n = 11, from Pisa) previously analysed for APA on monkey sections, while some T1D Sardinian patient sera (n = 22) were tested on monkey sections. According to preliminary experiments, positivity were considered ≥1:200 and ≥1:20 for bovine and monkey substrates, respectively.
Results and discussion
Using bovine sections, APA were detected in 7/100 Sardinian T1D patients (at 1:200 titer) and in none of the other Sardinian sera tested. When the T1D sera from Pisa were tested on bovine and the T1D Sardinian sera were tested on monkey, none of these sera showed corresponding positivity for APA. Pituitary hormone dysfunctions were not found in the 7 APA-positive Sardinian T1D patients. The present study shows that the presence of APA at low-titer is highly related to T1D but not associated with any pituitary dysfunction while the animal species used as substrate appears crucial.
Conclusion
Further studies are needed to ascertain whether APA detected by different animal species may have different pathological relevance in T1D and/or whether APA in the long run may predict future anterior pituitary dysfunction.
Similar content being viewed by others
References
Atkinson MA (2012) The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med 2:a007641
Lam-Tse WK, Batstra MR, Koeleman BP, Roep BO, Bruining MG, Aanstoot HJ, Drexhage HA (2003) The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes. Pediatr Endocrinol Rev 1:22–37
Bakker SF, Tushuizen ME, Stokvis-Brantsma WH, Aanstoot HJ, Winterdijk P, van Setten PA, von Blomberg BM, Mulder CJ, Simsek S (2013) Frequent delay of coeliac disease diagnosis in symptomatic patients with type 1 diabetes mellitus: clinical and genetic characteristics. Eur J Intern Med 24:456–460
Sumnik Z, Cinek O, Bratanic N, Lebl J, Rozsai B, Limbert C, Paskova M, Schober E (2006) Thyroid autoimmunity in children with coexisting type 1 diabetes mellitus and celiac disease: a multicenter study. J Pediatr Endocrinol Metab 19:512–517
Barker JM, Ide A, Hostetler C, Yu L, Miao D, Fain PR, Eisenbarth GS, Gottlieb PA (2005) Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison’s disease in a high-risk population. J Clin Endocrinol Metab 90:128–134
De Graaff LC, Martín-Martorell P, Baan J, Ballieux B, Smit JW, Radder JK (2011) Long-term follow-up of organ-specific antibodies and related organ dysfunction in type 1 diabetes mellitus. Neth J Med 69:66–71
Kobayashi T, Yabe S, Kikuchi T, Kanda T, Kobayashi I (1997) Presence of anti-pituitary antibodies and GAD antibodies in NIDDM and IDDM. Diabetes Care 20:864–866
Lupi I, Raffaelli V, Di Cianni G, Caturegli P, Manetti L, Ciccarone AM, Bogazzi F, Mariotti S, Del Prato S, Martino E (2013) Pituitary autoimmunity in patients with diabetes mellitus and other endocrine disorders. J Endocrinol Invest 36:127–131
Kobayashi T, Yabe S, Kanda T, Kobayashi I (1998) Studies on circulating anti-pituitary antibodies in NIDDM patients. Endocr J 45:343–350
De Bellis A, Sinisi AA, Conte M, Coronella C, Bellastella G, Esposito D, Pasquali D, Ruocco G, Bizzarro A, Bellastella A (2007) Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 92(2):604–607
De Bellis A, Iacovo AD, Bellastella G, Savoia A, Cozzolino D, Sinisi AA, Bizzarro A, Bellastella A, Giugliano D (2013) Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism. Pituitary. doi:10.1007/s11102-013-0526-9
Bellastella G, Rotondi M, Pane E, Iacovo AD, Pirali B, Mora LD, Falorni A, Sinisi AA, Bizzarro A, Colao A, Chiovato L, De Bellis A, Italian Autoimmune Hypophysitis Network Study (2010) Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. J Clin Endocrinol Metab 95:3750–3757
Bottazzo GF, Florin-Christensen A, Doniach D (1975) Autoantibodies to prolactin-secreting cells of human pituitary. Lancet 2:97–101
Mirakian R, Cudworth AG, Bottazzo GF, Richardson CA, Doniach D (1982) Autoimmunity to anterior pituitary cells and the pathogenesis of insulin-dependent diabetes mellitus. Lancet 1:755–759
Glück M, Scherbaum WA (1990) Substrate specificity for the detection of autoantibodies to anterior pituitary cells in human sera. Hum Metab Res 22(10):541–545
Ricciuti A, De Remigis A, Landek-Salgado MA, De Vincentiis L, Guaraldi F, Lupi I, Iwama S, Wand GS, Salvatori R, Caturegli P (2014) Detection of pituitary antibodies by immunofluorescence: approach and results in patients with pituitary diseases. J Clin Endocrinol Metab 99:1758–1766
Manetti L, Lupi I, Morselli LL, Albertini S, Cosottini M, Grasso L, Genovesi M, Pinna G, Mariotti S, Bogazzi F, Bartalena L, Martino E (2007) Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases. J Clin Endocrinol Metab 92:2176–2181
De Bellis A, Sinisi AA, Pane E, Iacovo AD, Bellastella G, Di Scala G, Falorni A, Giavoli C, Gasco V, Giordano R, Ambrosio MR, Colao A, Bizzarro A, Bellastella A (2012) Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. J Clin Endocrinol metab 97(10):3684–3690
Bensing S, Fetissov SO, Mulder J, Perheentupa J, Gustafsson J, Husebye ES, Oscarson M, Ekwall O, Crock PA, Hökfelt T, Hulting AL, Kämpe O (2007) Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proc Natl Acad Sci USA 104:949–954
Cocco C, Meloni A, Boi F, Pinna G, Possenti R, Mariotti S, Ferri GL (2005) Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome? J Clin Endocrinol Metab 90:4108–4111
Cocco C, Meloni A, Mariotti S, Cossu E, D’amato F, Zulian S, Tongiorgi E, Ferri GL (2012) Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1. Autoimmunity 45:485–494
Sugiura M, Hashimoto A, Shizawa M, Tsukada M, Maruyama S, Ishido T, Kasahara T, Hirata Y (1986) Heterogeneity of anterior pituitary cell antibodies detected in insulin-dependent diabetes mellitus and adrenocorticotropic hormone deficiency. Diabetes Res 3:111–114
Ho KK, 2007 GH Deficiency Consensus Workshop Participants (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157:695–700
Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614
De Bellis A, Bizzarro A, Conte M, Perrino S, Coronella C, Solimeno S, Sinisi AM, Stile LA, Pisano G, Bellastella A (2003) Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. J Clin Endocrinol Metab 88:650–655
Cambuli VM, Galdiero M, Mastinu M, Pigliaru F, Auriemma RS, Ciresi A, Pivonello R, Amato M, Giordano C, Mariotti S, Colao A, Baroni MG (2012) Glycometabolic control in acromegalic patients with diabetes: a study of the effects of different treatments for growth hormone excess and for hyperglycemia. J Endocrinol Invest 35:154–159
Acknowledgments
Supported by grants from University of Cagliari to SM and from Italian MIUR-PRIN (#2002067915_002 to GLF, #2002067915_001 to SM).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
C. Pisanu and C. Cocco contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Pisanu, C., Cocco, C., Cossu, E. et al. Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations. J Endocrinol Invest 37, 973–978 (2014). https://doi.org/10.1007/s40618-014-0135-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-014-0135-0